Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A Wall Street analyst says Walmart’s setup for beating the market over the near term looks less persuasive, pointing to challenges tied to its pharmacy business.
THE APEX TIMES
THE APEX TIMES
The drugmaker said its Covid-19 portfolio is no longer expected to drag results as much as previously thought, and is pointing to revenue resilience from its established specialty franchises.
THE APEX TIMES
Leidos Holdings reported second-quarter 2026 results and raised guidance, giving investors a fresh look at the company’s near-term earnings trajectory after recent contract wins and capital returns.
THE APEX TIMES
A Q2 earnings miss raised questions about near-term results for Exxon Mobil, but a separate set of fundamentals, including ongoing production and the level of oil prices, is shaping how investors read the outlook.
THE APEX TIMES
The fast-food chain reported a quarter that topped Wall Street expectations and named a new head of its U.S. business, a move investors are likely to watch for execution in the next phase of its turnaround.
THE APEX TIMES
The biotech said it has begun testing a vaccine designed to target a species of ebolavirus linked to a deadly outbreak in the Democratic Republic of the Congo, a move that prompted investors to bid up its stock.
THE APEX TIMES
An Oppenheimer view of Walmart’s stock outlook points to more muted near-term upside, even as analysts continue to weigh longer-range resilience in a pressured retail environment.
THE APEX TIMES
Analysts at UBS told investors that Walmart’s next-quarter growth could slow, driven less by demand weakening and more by how product and pricing mix plays against tougher year-ago comparisons.
THE APEX TIMES
A new account of Goldman’s strategy describes an effort to embed artificial intelligence across the company to improve efficiency, support fee growth, and drive broader operating-model change.
